Cancer News and Research

Latest Cancer News and Research

Childhood cancer survival varies by tumor stage at diagnosis

A major study by UCL and Fondazione IRCCS Istituto Nazionale dei Tumori in Milan (INT) researchers has for the first time shown in detail how far children's cancer has spread at diagnosis in a way that can be compared between countries.

9 Feb 2026

FDA label update expands CAR T access for primary CNS lymphoma

Dana-Farber Cancer Institute-led research helped drive an FDA label update for axicabtagene ciloleucel (Yescarta) that removes a prior exclusion for patients with primary central nervous system lymphoma, a rare and aggressive lymphoma of the brain and spinal cord.

9 Feb 2026

Newly identified protein interaction fine-tunes cellular stress responses

Cornell researchers have discovered a new way cells regulate how they respond to stress, identifying an interaction between two proteins that helps keep a critical cellular recycling system in balance.

9 Feb 2026

Engineered CAR-T cells reduce Alzheimer’s plaques in mice

Chimeric antigen receptor (CAR) T cell therapy, a type of immunotherapy that leverages the immune system to combat diseases, is a powerful treatment option for certain cancers.

9 Feb 2026

Chronic brain compression triggers neuron death through multiple pathways

To think, feel, talk and move, neurons send messages through electrical signals in the brain and spinal cord.

9 Feb 2026

New analysis asks if alcohol guidance needs stronger trials to settle the health debate

The viewpoint reviews conflicting evidence on alcohol consumption, highlighting discrepancies between observational studies, genetic analyses, and public health guidance. It concludes that large randomized trials comparing alcohol moderation versus cessation are needed to clarify long-term health effects.

9 Feb 2026

Nervous system actively promotes pre-cancerous pancreatic lesions

Pancreatic cancer has a lot of nerve. Notoriously tricky to detect, the disease also often resists traditional therapy. So, researchers are urgently looking for new ways to disrupt tumor formation.

9 Feb 2026

PSMA PET/CT scans may predict prostate cancer recurrence, guide treatment

New research in the February 2026 issue of JNCCN-Journal of the National Comprehensive Cancer Network found that incorporating information from prostate-specific membrane antigen (PSMA) PET/CT scans may be able to predict progression-free survival (PFS) and guide treatment planning in patients with rising prostate-specific antigen (PSA) levels following removal of the prostate.

9 Feb 2026

IRF7 reshapes the behavior of vascular smooth muscle cells during atherosclerosis

Atherosclerosis underlies most heart attacks and strokes and is now recognized as a chronic inflammatory disease rather than a simple disorder of cholesterol deposition.

9 Feb 2026

Cannabis legalization may lead to a decline in daily opioid use

Legalizing cannabis for both medical and recreational use may lead to a decline in daily opioid use among people who inject drugs in the United States, according to a new study led by a Boston University School of Public Health researcher (BUSPH).

9 Feb 2026

New nanoparticle separation method boosts biotech and cancer research

In nanoscale particle research, precise control and separation have long been a bottleneck in biotechnology. Researchers at the University of Oulu have now developed a new method that improves particle separation and purification.

9 Feb 2026

Menstrual blood HPV testing accurately detects cervical precancer

A study reveals menstrual blood can effectively screen for HPV, matching clinician-collected samples in accuracy, enhancing cervical cancer detection globally.

9 Feb 2026

Historical redlining's impact on breast cancer survival changes over time

Historical redlining, a 1930s–1960s residential segregation policy, has been linked to shorter survival time in people with breast cancer.

9 Feb 2026

Mesothelial cells enable rapid invasion and spread of ovarian cancer

Ovarian cancer kills more women than any other gynecological cancer. Most patients receive their diagnosis only after the disease spreads throughout the abdomen.

7 Feb 2026

Cholesterol transporter ABCA1 boosts macrophage-driven cancer immunity

In recent years, cancer researchers have made major breakthroughs by using the body's immune system to fight cancer. One of the most promising approaches, known as immune checkpoint blockade, works by releasing molecular "brakes" on T cells.

7 Feb 2026

Tumor-targeted chimeric drug increases efficacy and limits side effects

Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more effectively.

7 Feb 2026

American women show varied preferences for in-clinic versus at-home cervical cancer screening

American women now have the option of screening for cervical cancer at home, using newly approved self-collection tools.

7 Feb 2026

Water pressure mechanism enables fast amoeboid cancer cell movement

Cancer is one of the leading causes of death worldwide, marked by the uncontrolled growth of abnormal cells.

7 Feb 2026

RNA micelles enable targeted chemotherapy without immune toxicity

A new study in mice hints at the potential to use tiny particles made with RNA molecules to deliver chemotherapy drugs and other therapies directly to tumors, killing cancer cells without generating an immune response or toxicity-related side effects.

7 Feb 2026

Bioadhesive patches target remaining glioblastoma cells after surgery

Glioblastoma is the most prevalent and aggressive brain tumor. It proliferates very rapidly, is highly invasive, and there is currently no treatment capable of halting its progression or curing it, which means life expectancy after diagnosis is very short.

6 Feb 2026